Breaking News: European Study Reports Halting of Progress of Type 1 Diabetes by Drug Anti-CD3 Antibody

Breaking News: European Study Reports Halting of Progress of Type 1 Diabetes by Drug Anti-CD3 Antibody

Note: This article will be emailed to your friend.

The European study of patients with Type I diabetes found that short-term treatment lowered insulin dependence by 12 percent and increased insulin-making capabilities for at least 18 months.
“The results are very promising. There are not many instances where you can stop an autoimmune disease in its tracks,” said Dr. Richard Insel, executive vice president for [...]

Read the rest of this article (235 words)

Please fill in the following fields

* - Required

Your Name: *

Your E-Mail: *

Your Remarks:

Friend's Name: *

Friend's E-Mail: *

Protected by Comment Guard Pro